anticoagulants

Anthos hails win over Xarelto with novel anticoagulant
Anthos hails win over Xarelto with novel anticoagulant
Pharmaphorum
Anthos Therapeutics
clinical trials
abelacimab
Xarelto
anticoagulants
atrial fibrillation
Flag link:
Anthos Therapeutics is Developing a Hemostasis-Sparing Anticoagulant to Reduce the Hazard of Bleeding
Anthos Therapeutics is Developing a Hemostasis-Sparing Anticoagulant to Reduce the Hazard of Bleeding
BioSpace
Anthos Therapeutics
anticoagulants
Flag link:
Verseon to Initiate Ph I Study of New Class Anticoagulant with Reduced Bleeding Risk
Verseon to Initiate Ph I Study of New Class Anticoagulant with Reduced Bleeding Risk
CP Wire
Verseon
VE-1902
anticoagulants
Flag link:
Verseon to Initiate Ph I Study of New Class Anticoagulant with Reduced Bleeding Risk
Verseon
VE-1902
anticoagulants
Flag link:
[video]How Portola Is Looking to Change the Anticoagulant Game
[video]How Portola Is Looking to Change the Anticoagulant Game
Motley Fool
Portola Pharmaceuticals
anticoagulants
Bevyxxa
JNJ
Pfizer
Flag link:
Boehringer seeks real-world data to support reversal agent
Boehringer seeks real-world data to support reversal agent
BioPharma Dive
Boehringer Ingelheim
Praxbind
Pradaxa
anticoagulants
anticoagulant reversal
Flag link:
3 Healthcare Trends Johnson & Johnson Told Us About This Earnings Season
3 Healthcare Trends Johnson & Johnson Told Us About This Earnings Season
Motley Fool
JNJ
earnings
emerging markets
anticoagulants
Flag link:
Bayer fronting $155M for a promising anticoagulant from Isis Pharma
Bayer fronting $155M for a promising anticoagulant from Isis Pharma
Fierce Biotech
Bayer
anticoagulants
Isis Pharmaceuticals
ISIS-FXI
antisense
Flag link:
Could This Drug Make Isis Pharmaceuticals Soar?
Could This Drug Make Isis Pharmaceuticals Soar?
Investopedia
Isis Pharmaceuticals
anticoagulants
ISIS-FXIRx
Flag link:
FDA Places Clinical Hold On Phase 3 Trial Of Novel Anticoagulant
FDA Places Clinical Hold On Phase 3 Trial Of Novel Anticoagulant
Forbes
FDA
Regado Biosciences
anticoagulants
Revolixys
Flag link:
Regado Halts Big Heart Drug Trial, Shares Hammered
Regado Halts Big Heart Drug Trial, Shares Hammered
Motley Fool
Regado Biosciences
clinical trials
REG1
anticoagulants
Flag link:
FDA Grants New Indication For Pfizer/Bristol Anticoagulant
FDA Grants New Indication For Pfizer/Bristol Anticoagulant
Forbes
Pfizer
DVT
Bristol-Myers Squibb
Apixaban
anticoagulants
Eliquis
Flag link:
Bayer rival Boehringer seeks wider use of anti-clotting pill
Bayer rival Boehringer seeks wider use of anti-clotting pill
Reuters
Bayer
Boehringer Ingelheim
anticoagulants
Pradaxa
deep vein thrombosis
pulmonary embolism
Flag link:
Roller Coaster Path To Approval For Eliquis Uncovered By FDA Documents
Roller Coaster Path To Approval For Eliquis Uncovered By FDA Documents
Forbes
Eliquis
FDA
Pfizer
Bristol-Myers Squibb
anticoagulants
Flag link:
Boehringer anti-clotting pill gains blockbuster status
Boehringer anti-clotting pill gains blockbuster status
Reuters
anticoagulants
Boehringer Ingelheim
Pradaxa
Flag link:
Studies Examine Novel Use For New Oral Anticoagulant Drugs Comment Now Follow Comments
Studies Examine Novel Use For New Oral Anticoagulant Drugs Comment Now Follow Comments
Forbes
anticoagulants
dabigatran
Apixaban
Flag link:
Blood Thinner From Pfizer, Bristol-Myers Blocks Leg Clots
Blood Thinner From Pfizer, Bristol-Myers Blocks Leg Clots
Bloomberg
Bristol-Myers Squibb
Pfizer
Eliquis
blood thinners
anticoagulants
Flag link:
The Battle For The Anti-Coagulation Market
The Battle For The Anti-Coagulation Market
Seeking Alpha
anticoagulants
Pfizer
Sanofi
Bristol-Myers Squibb
Flag link:
Study Finds Risk in New Stroke Drug Pradaxa
Study Finds Risk in New Stroke Drug Pradaxa
WSJ Online
Pradaxa
stroke
anticoagulants
Boehringer Ingelheim
Flag link:
Apixaban- Pfizer's Multi-Billion Dollar Income Replacement For Lipitor
Apixaban- Pfizer's Multi-Billion Dollar Income Replacement For Lipitor
Seeking Alpha
Apixaban
Pfizer
anticoagulants
Flag link:

Pages